Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Piebaldism × Imatinib Mesylate × Clear all

Phase

Status

Completed 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Rare Tumour 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Piebaldism 1 Gastrointestinal Stromal Tumors 1

Interventions

Mastectomy, Segmental 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05970900 2023-08-01

PIRKER

Fujian Medical University Union Hospital

Phase 3 Not yet recruiting

GastrointestinalSarcoma

Piebaldism, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡